BiotechTube
Home/Bolden Therapeutics/Anne Valat, PhD
AV

Anne Valat, PhD

Director of Research

Bolden Therapeutics

Therapeutic Areas

NeurologyPsychiatry

Bolden Therapeutics Pipeline

DrugIndicationPhase
Neurogenesis PlatformMultiple Neurological Disorders (Alzheimer's, Stroke, Depression, etc.)Pre-clinical

Leadership Team at Bolden Therapeutics

JP
Johnny Page, ScM
Co-Founder & CEO
CP
Charles Polsky, MD
Executive Chairman
JR
Justin R. Fallon, PhD
Scientific Founder, SAB Chair
AE
Ashley E. Webb, PhD
Scientific Founder, SAB Member
View full Bolden Therapeutics profile